Galmed Pharmaceuticals Aktie
8,60
EUR
-1,10
EUR
-11,34
%
1,21
USD
±0,00
USD
±0,00
%
Werbung
Galmed Pharmaceuticals Aktie Analyse
| 12.12.18 | Galmed Pharmaceuticals Buy | B. Riley FBR | |
| 02.08.18 | Galmed Pharmaceuticals Buy | Maxim Group | |
| 13.07.18 | Galmed Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
| 12.07.18 | Galmed Pharmaceuticals Outperform | Imperial Capital | |
| 12.06.18 | Galmed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 15.03.18 | Galmed Pharmaceuticals Buy | Maxim Group | |
| 14.02.18 | Galmed Pharmaceuticals Hold | Maxim Group | |
| 12.02.18 | Galmed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 08.08.17 | Galmed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 31.07.17 | Galmed Pharmaceuticals Buy | Maxim Group | |
| 28.03.16 | Galmed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 23.06.15 | Galmed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 15.04.15 | Galmed Pharmaceuticals Buy | ROTH Capital Partners, LLC | |
| 24.09.14 | Galmed Pharmaceuticals Buy | MLV Capital | |
Werbung
Werbung